Background illustration for clinical trials search

Paid Clinical Trials Kent

Discover 1,441 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease

for
Medulloblastoma, Medulloblastoma, Childhood,
Location: Seattle WA, Washington D.C. DC
Sponsor: Sabine Mueller, MD, PhD

Sex: All

Age: 1 - 25

Code: NCT07346157

Phase1, Phase2, Recruiting

Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder

for
GRIN-related Neurodevelopmental Disorder
Location: Seattle WA, Palo Alto CA, Los Angeles CA, Aurora CO,
Sponsor: GRIN Therapeutics, Inc.

Sex: All

Age: 0 - 18

Code: NCT07224581

Phase3, Recruiting

I-DECIDE After Bronchiolitis Hospitalization

for
Bronchiolitis Acute
Location: Seattle WA, Vancouver, Calgary, Sacramento CA, Lodi CA,
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 2

Code: NCT07243652

Recruiting

Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer

for
Adenocarincoma of Pancreas, Stage III Pancreatic Cancer,
Location: Seattle WA
Sponsor: Seattle Cancer Treatment and Wellness Center

Sex: All

Age: 18 - 65

Code: NCT00323583

Phase2, Recruiting

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

for
Focal Seizures
Location: Seattle WA, Portland OR, Murray UT, La Jolla CA,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT07233239

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

for
Solid Tumor (Excluding CNS), Liver Cell Carcinoma,
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 1 - 26

Code: NCT07148050

Phase1, Recruiting

Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.

for
Diabetes Mellitus, Type 1 Diabetes
Location: Seattle WA
Sponsor: University of British Columbia

Sex: All

Age: 16 - 19

Code: NCT07292558

Recruiting

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

for
Adamantinomatous Craniopharyngioma,
Location: Seattle WA, Edmonton, Aurora CO, Houston TX,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 39

Code: NCT05233397

Phase2, Recruiting

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

for
Heart Failure, Cardiogenic Shock, Congenital Heart Disease,
Location: Seattle WA, Palo Alto CA, Dallas TX, Durham NC,
Sponsor: Stanford University

Sex: All

Age: 0 - 16

Code: NCT06080074

Phase2, Recruiting

A Retrospective Study to Characterize Participants With Propionic Acidemia

for
Propionic Acidemia
Location: Seattle WA, Baltimore MD, Philadelphia PA
Sponsor: ModernaTX, Inc.

Sex: All

Age: 2+

Code: NCT05769621

Recruiting

De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia

for
Congenital Diaphragmatic Hernia
Location: Seattle WA, Portland OR, Palo Alto CA,
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 0

Code: NCT05213676

Recruiting

The "What Is Important to Us" Communication Intervention Pilot Clinical Trial

for
Critical Illness, Neurologic Disorder
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0+

Code: NCT06208332

Phase2, Recruiting

A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT

for
Adenovirus Infections
Location: Seattle WA, Sacramento CA, Duarte CA, Phoenix AZ,
Sponsor: SymBio Pharmaceuticals

Sex: All

Age: 0+

Code: NCT07387367

Phase3, Recruiting

Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study

for
Congenital Heart Disease, Congenital Heart Disease (CHD)
Location: Seattle WA, Stanford CA, Los Angeles CA, Aurora CO,
Sponsor: Starlight Cardiovascular Inc

Sex: All

Age: 0

Code: NCT07114718

Recruiting

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

for
Chronic Kidney Disease
Location: Seattle WA, Vancouver, Edmonton, Salt Lake City UT,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 2 - 17

Code: NCT07107945

Phase3, Recruiting

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

for
Diffuse Intrinsic Pontine Glioma, DIPG, Brain Tumor, CNS Tumor,
Location: Seattle WA
Sponsor: BrainChild Bio, Inc

Sex: All

Age: 1 - 26

Code: NCT07680439

Phase2, Recruiting

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

for
Tuberous Sclerosis Complex, Epilepsy
Location: Seattle WA, Palo Alto CA, Los Angeles CA, Aurora CO,
Sponsor: Darcy Krueger

Sex: All

Age: 0

Code: NCT05104983

Phase2, Recruiting

Familial Inflammatory Bowel Disease Early Risk

for
Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis),
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 55

Code: NCT07791862

Recruiting

A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

for
Cancer, Medication Adherence
Location: Seattle WA, Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 15 - 24

Code: NCT07223463

Recruiting

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Everett WA, Palo Alto CA, Los Angeles CA, Rapid City SD,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06878261

Phase3, Recruiting